ABSTRACT Carboxyhaemoglobin and plasma thiocyanate concentrations were measured in 79 non-smokers and 360 cigarette smokers. The mean levels were 0 73% and 7*09% carboxy- 
Twenty to thirty-five per cent of smokers attending clinics and claiming to have stopped smoking have been shown not to have done so.'-' Consequently, to assess the impact of antismoking strategies biochemical tests are being increasingly used as an independent validation of such claims. Unfortunately even with these tests some smokers and nonsmokers cannot be distinguished with certainty. Vogt5 has suggested that discrimination between the groups may be improved by combining two of the tests-namely, estimation of alveolar carbon monoxide and serum thiocyanate. Indeed, he reported that when the two measurements agreed 99% of the predictions proved correct. In one-tenth of his population, however, the two tests disagreed and assigned subjects to opposite groups. In these instances a means of interpreting the contradictory results is necessary or the tests become meaningless. No such method has yet been suggested.
We have reassessed the ability of carboxyhaemoglobin and plasma thiocyanate estimations to distinguish between smokers and non-smokers, and have also used the statistical technique of discriminant analysis to weight these measures to predict the group to which subjects with conflicting values are most likely to belong.
Methods
All the subjects were volunteers who had no reason to conceal their true smoking habits. They were smoking and non-smoking members of staff of St Bartholomew's Hospital and smokers attending the addiction research unit at the Maudsley Hospital. The subjects were assigned to one of two groups on the basis of their reported smoking habits. The first group consisted of 360 cigarette smokers (178 men and 182 women) who had not altered their usual smoking behaviour. In the second group there were 79 non-smokers (51 men and 28 women).
Venous blood was taken from each subject, usually in the afternoon or late morning, into a heparinised syringe and kept at 4°C. Carboxyhaemoglobin was measured within 48 hours with an IL282 CO-Oximeter, the accuracy of which was crosschecked with a gas chromatographic method.6 The remaining blood was centrifuged and the plasma separated and stored at -20°C until analysed for thiocyanate. In this estimation plasma (0.5 ml) was mixed with 5% trichloracetic acid (4. 
Discussion
To distinguish between smokers and non-smokers an index compound should ideally satisfy the following criteria: (1) be specific for tobacco smoke; (2) be unaffected by genetic, nutritional, or environmental differences; (3) have a long half-life; and (4) be easy to analyse accurately. The most common of such compounds in current use-carbon monoxide, thiocyanate, nicotine, and cotinine-do not completely fulfil these requirements.
Blood or urinary nicotine and cotinine are probably the most specific indicators of smoking available, and while these substances may be detected in non-smokers as a result of passive smoking high concentrations are unusual.' "1 They both, however, have a shorter half-life than thiocyanate and are not as easy to measure as carboxyhaemoglobin. Furthermore, where chewing gum containing nicotine is Table 2 Percentage ofself-reported non-smokers and smokers misclassified on the basis ofthe specified limiting values of carboxyhaemoglobin (COHb) orplasma thiocyanate (SCN) and by discriminant analysis (z) (subjects with values less than or equal to the cut-offpoint are considered to be non-smokers) (table 1) . Pyrolysis of tobacco produces up to 5% carbon monoxide and 0 16% hydrogen cyanide in the gas phase, as well as organic cyanide compounds (nitriles-about 1 mg a cigarette) in the particulate phase. Most of the carbon monoxide and hydrogen cyanide (and its compounds) is absorbed through the lungs. In addition, some hydrogen cyanide is absorbed through the buccal and nasal mucosa. Both the free hydrogen cyanide and that released during the metabolism of the nitriles is converted to thiocyanate by the mitochondrial enzyme rhodanese.
Carboxyhaemoglobin and plasma thiocyanate each identified correctly the group to which over 90% of our subjects belonged (table 2) . These results are similar to those reported by Vogt-and better than those of Cohen and Bartsch.'s The very high levels of carboxyhaemoglobin (¢ 6%) and thiocyanate (-200 ,umol/l) found in some of the non-smoking subjects in the latter study make it possible that some of those claiming to be nonsmokers were in fact smokers; this would explain the reduced specificity and sensitivity of the tests in this case.
In nine of our smoking subjects both carboxyhaemoglobin and -thiocyanate levels were within the non-smoking range (table 5). Most of these people consumed relatively few cigarettes, while others might have been non-inhalers. These factors may account for the atypical results and no biochemical test is likely to identify such individuals.
The object of using discriminant analysis was to weight and linearly combine the discriminating variables (carboxyhaemoglobin and thiocyanate) in such a manner that the groups (smokers and nonsmokers) are forced to be as statistically distinct as possible. The chief benefit of this analysis was in deciding the group to which subjects with contradictory carboxyhaemoglobin and thiocyanate classifications belonged. There were 26 such subjects and 21 of these were successfully grouped with the help of the function z (table 3) . But as z achieved only a marginally better overall classification than that obtained with carboxyhaemoglobin there appears to be no real advantage in making both biochemical measurements. Indeed, thiocyanate estimation is a more complicated procedure than the procedure for determining carboxyhaemoglobin levels with the CO-Oximeter; and the extra expense, analysis time, and labour required in measuring thiocyanate cannot be justified. The one major advantage of thiocyanate derives from the long half-life (14 days) of this anion in plasma.'6 Carboxyhaemoglobin, on the other hand, has a half-life of only 3 1 hours in subjects engaged in light activity, increasing to 6*9 hours during sleep.'7 Carboxyhaemoglobin is therefore more susceptible to the effects of short-term changes in smoking habits. Thus if subjects stop smoking for 24 hours before blood sampling carboxyhaemoglobin levels can fall to within the non-smoking range, whereas the plasma thiocyanate concentration will be virtually unaffected.
The cut-off points used in this study may not be applicable to studies in which different analytical procedures are used. There are no standardised techniques for measuring either carboxyhaemoglobin or thiocyanate and systematic errors between different methods may arise.'819 Published means for these measures in non-smokers show considerable variation23202' and each laboratory must therefore determine its own normal values. The COOximeter gave results with excellent repeatability6 and is easy to use and rapid (an analysis takes only one minute). Our thiocyanate method also has a good precision; routine analysis of two batches of pooled plasma over three months gave means and standard deviations of 46*1 + 2*4 and 117-8 ± 6.4 ,umol SCN/l plasma (n= 50). This analysis, however, is slower (only 20 plasma samples are processed in an hour) and requires costly reagents.
In conclusion, our results indicate that the ability to distinguish between smokers and non-smokers is only marginally enhanced by combining carboxyhaemoglobin and thiocyanate measurements. In most instances carboxyhaemoglobin estimation alone is sufficient to decide whether a person is smoking. Measurement of thiocyanate, however, may be preferable, because of its longer half-life, in people who show erratic smoking patterns or are making intermittent attempts to stop smoking. 
